GHSR-1 targeting compounds


In this project, we will evaluate how Helsinn Healthcare’s compounds can influence the ghrelin receptor (GHSR-1a) structure and activity. This analysis will elucidate the characteristics governing the compounds effect at receptor level. The goals of the project will be represented by the identification of relevant biophysical and biochemical information able to discriminate different types of compounds effect, fundamental data for both the tailoring of the current GHSR-1a targeting platform and a future rationale design of new drugs.


Back to Research ongoing

IDSIA – Dalle Molle Institute for Artificial Intelligence Studies